BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding H, Fan GL, Yi YX, Zhang W, Xiong XX, Mahgoub OK. Prognostic Implications of Immune-Related Genes' (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer. Front Genet 2020;11:725. [PMID: 32793281 DOI: 10.3389/fgene.2020.00725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Zheng J, Cai Z, Li W, Köhler J, Dai Y, Cheng X, Wu T, Zhang F, Wang H. Therapeutic Response-Based Reclassification of Multiple Tumor Subtypes Reveals Intrinsic Molecular Concordance of Therapy Across Histologically Disparate Cancers. Front Cell Dev Biol 2021;9:773101. [PMID: 34869372 DOI: 10.3389/fcell.2021.773101] [Reference Citation Analysis]
2 Jia E, Ren N, Guo B, Cui Z, Zhang B, Xue J. Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02509-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Cheng Y, Zhang S, Qiang Y, Dong L, Li Y. Integrated bioinformatics data analysis reveals a risk signature and PKD1 induced progression in endometrial cancer patients with postmenopausal status. Aging. [DOI: 10.18632/aging.204168] [Reference Citation Analysis]
4 Li X, Cheng Y, Cheng Y, Shi H. Transcriptome Analysis Reveals the Immune Infiltration Profiles in Cervical Cancer and Identifies KRT23 as an Immunotherapeutic Target. Front Oncol 2022;12:779356. [DOI: 10.3389/fonc.2022.779356] [Reference Citation Analysis]
5 Zhang X, Li X, Xie J, Zhu Q, Yuan Y. A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma. J Oncol 2022;2022:8909631. [PMID: 35342420 DOI: 10.1155/2022/8909631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Cheng Y, Li X, Dai Y, Dong Y, Yang X, Wang J. Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer. J Gynecol Oncol 2021;32:e30. [PMID: 33559412 DOI: 10.3802/jgo.2021.32.e30] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Yang X, Cheng Y, Li X, Zhou J, Dong Y, Shen B, Zhao L, Wang J. A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation. Onco Targets Ther 2021;14:2579-98. [PMID: 33880037 DOI: 10.2147/OTT.S293085] [Reference Citation Analysis]
8 Zhong QH, Zha SW, Lau ATY, Xu YM. Recent knowledge of NFATc4 in oncogenesis and cancer prognosis. Cancer Cell Int 2022;22:212. [PMID: 35698138 DOI: 10.1186/s12935-022-02619-6] [Reference Citation Analysis]
9 Meng D, Jin H, Zhang X, Yan W, Xia Q, Shen S, Xie S, Cui M, Ding B, Gu Y, Wang S. Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer. Cancer Cell Int 2021;21:362. [PMID: 34238288 DOI: 10.1186/s12935-021-02073-w] [Reference Citation Analysis]
10 Yu S, Li X, Zhang J, Wu S. Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer. Front Immunol 2021;12:709493. [PMID: 34539641 DOI: 10.3389/fimmu.2021.709493] [Reference Citation Analysis]
11 Budhwani M, Turrell G, Yu M, Frazer IH, Mehdi AM, Chandra J. Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients. Front Mol Biosci 2021;8:622643. [PMID: 33834038 DOI: 10.3389/fmolb.2021.622643] [Reference Citation Analysis]